Olivier Loeillot serves as Executive at REPLIGEN CORP, where they oversee executive responsibilities. Since joining the company, Olivier Loeillot has executed 5 insider transactions totaling $1.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 25, 2025 involved selling 7,041 shares valued at $1.2M.
Olivier Loeillot currently holds 35,898 shares of REPLIGEN CORP (RGEN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Olivier Loeillot has been a net seller of RGEN stock. They have purchased $0 and sold $1.2M worth of shares.
Olivier Loeillot's most recent insider trade was on Nov 25, 2025, when they sold 7,041 shares at $170.00 per share.
Get notified when new Form 4 filings are submitted
| $145.23 |
| Discretionary |
| Sep 3, 2024 | RGEN | $0 | Award | 17,631 | $N/A | Discretionary |
| Feb 27, 2024 | RGEN | $0 | Award | 2,880 | $N/A | Discretionary |
| Oct 2, 2023 | RGEN | $0 | Award | 12,906 | $N/A | Discretionary |